Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC.
Plaintiff: Silvergate Pharmaceuticals, Inc.
Defendant: Amneal Pharmaceuticals LLC.
Case Number: 1:2020cv01255
Filed: September 18, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Leonard P Stark
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on November 12, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 12, 2020 Opinion or Order SO ORDERED, re #24 MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox, Jeremy J. Edwards, Esquire, Matthew C. Ruedy, Esquire, Kaveh V. Saba, Esquire and Anthony H. Son, Esquire filed by Amneal Pharmaceuticals LLC. Signed by Judge Leonard P. Stark on 11/12/20. (ntl)
November 12, 2020 Opinion or Order SO ORDERED, re #19 STIPULATION to File Letter Under Seal filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 11/12/20. (ntl)
November 10, 2020 Filing 24 MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox, Jeremy J. Edwards, Esquire, Matthew C. Ruedy, Esquire, Kaveh V. Saba, Esquire and Anthony H. Son, Esquire - filed by Amneal Pharmaceuticals LLC.. (Wilson, Samantha)
November 9, 2020 Filing 23 Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Pending Motions. (Dellinger, Megan)
November 9, 2020 Filing 22 Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Bionpharma Inc.'s Motion for Leave to File a Response to Amneals Cross-Motion to Consolidate - re (20 in 1:20-cv-01255-LPS) Letter, (125 in 1:19-cv-00678-LPS) Letter. (Attachments: #1 Exhibit A)(Gaza, Anne)
November 9, 2020 Filing 21 REPLY BRIEF re #15 Cross MOTION to Consolidate Cases filed by Amneal Pharmaceuticals LLC.. (Gaza, Anne)
November 6, 2020 Filing 20 [SEALED] Letter to Honorable Leonard P. Stark from Kenneth L. Dorsney regarding Recent Filings. (Attachments: #1 Attachments (1-3), #2 Certificate of Service)(Dorsney, Kenneth)
November 6, 2020 Filing 19 STIPULATION File Letter Under Seal by Bionpharma Inc.. (Dorsney, Kenneth)
November 5, 2020 Filing 18 [SEALED] BRIEF (Combined Answering and Reply) -- Reply Brief in Support of Motion for Consolidation and Answering Brief in Opposition to Amneal's Cross Motion to Consolidate re #10 MOTION to Consolidate Cases , #15 Cross MOTION to Consolidate Cases filed by Silvergate Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 11/12/2020. (Dellinger, Megan)
October 30, 2020 Filing 17 Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Cross-Motion to Consolidate - re (118 in 1:19-cv-00678-LPS, 15 in 1:20-cv-01255-LPS) Cross MOTION to Consolidate Cases . (Attachments: #1 Attachment 1, #2 Attachment 2)(Gaza, Anne)
October 30, 2020 Filing 16 BRIEF (Combined Opening and Answering) re #15 Cross MOTION to Consolidate Cases , #10 MOTION to Consolidate Cases filed by Amneal Pharmaceuticals LLC..Answering Brief/Response due date per Local Rules is 11/13/2020. Reply Brief due date per Local Rules is 11/6/2020. (Attachments: #1 Attachment)(Gaza, Anne)
October 30, 2020 Filing 15 Cross MOTION to Consolidate Cases - filed by Amneal Pharmaceuticals LLC., Amneal Pharmaceuticals LLC. (Attachments: #1 D. Del. LR 7.1.1. Statement)(Gaza, Anne)
October 29, 2020 Filing 14 REDACTED VERSION of (11 in 1:20-cv-01255-LPS) Opening Brief in Support, (116 in 1:19-cv-00678-LPS) Opening Brief in Support, by Silvergate Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A)(Dellinger, Megan)
October 27, 2020 Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc. for Amneal Pharmaceuticals LLC. filed by Amneal Pharmaceuticals LLC.. (Gaza, Anne)
October 27, 2020 Filing 12 ANSWER to Amended Complaint, re: #7 Amended Complaint , COUNTERCLAIM against Silvergate Pharmaceuticals, Inc. by Amneal Pharmaceuticals LLC..(Gaza, Anne)
October 22, 2020 Filing 11 [SEALED] OPENING BRIEF in Support re #10 MOTION to Consolidate Cases filed by Silvergate Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 11/5/2020. (Attachments: #1 Exhibit A)(Dellinger, Megan)
October 22, 2020 Filing 10 MOTION to Consolidate Cases - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
October 13, 2020 Opinion or Order SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendant Amneal Pharmaceuticals LLC to move against, answer, or otherwise respond to the Amended Complaint to October 27, 2020 filed by Amneal Pharmaceuticals LLC.. Signed by Judge Leonard P. Stark on 10/13/20. (ntl)
October 9, 2020 Filing 9 STIPULATION TO EXTEND TIME for Defendant Amneal Pharmaceuticals LLC to move against, answer, or otherwise respond to the Amended Complaint to October 27, 2020 - filed by Amneal Pharmaceuticals LLC.. (Gaza, Anne)
September 30, 2020 Filing 8 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,772,868 B2 ;10,786,482 B2 (Amended). (Dellinger, Megan)
September 30, 2020 CORRECTING ENTRY: Removed the patent report from #7 Amended Complaint per request of counsel. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
September 29, 2020 Filing 7 AMENDED COMPLAINT against Amneal Pharmaceuticals LLC.- filed by Silvergate Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B (Dellinger, Megan) Modified on 9/30/2020 (ntl).
September 23, 2020 Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (rjb)
September 21, 2020 Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal)
September 18, 2020 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Azurity Pharmaceuticals, Inc. for Silvergate Pharmaceuticals, Inc. filed by Silvergate Pharmaceuticals, Inc.. (mal)
September 18, 2020 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,772,868 B2. (mal)
September 18, 2020 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not applicable. Date of Expiration of Patent: 3/25/2036.Thirty Month Stay Deadline: 8/28/2021*. * This is the deadline from C.A. No. 19-678 (mal).
September 18, 2020 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
September 18, 2020 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Amneal Pharmaceuticals LLC. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3209860.) - filed by Silvergate Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Silvergate Pharmaceuticals, Inc.
Represented By: Jack B. Blumenfeld
Represented By: Megan Elizabeth Dellinger
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Amneal Pharmaceuticals LLC.
Represented By: Anne Shea Gaza
Represented By: Samantha G. Wilson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?